文献速递复苏、休克与脓毒症心脑血管急症

复苏性主动脉腔内球囊阻断术用于难治性院外心脏骤停:基于Utstein的病例系列

Resuscitative endovascular occlusion of the aorta (REBOA) for refractory out of hospital cardiac arrest. An Utstein-based case series.
PubMed 文献 · Resuscitation · 2021-06-03
一句话结论对≥15分钟CPR且不适合ECPR的难治性院外心脏骤停,REBOA在急诊科和院前均可放置,球囊充气后多数出现一过性ROSC,但持续ROSC仅5/18。

本研究为基于Utstein的病例系列,纳入2019—2020年连续20例难治性院外心脏骤停(CPR≥15分钟)且因临床或后勤原因不适合ECPR的患者,在急诊科及当地HEMS服务的院前环境中尝试REBOA。18/20例成功置管,2例失败与反复动脉穿刺失败有关;从EMS调度到尝试置管的中心时间为46分钟;球囊充气后12/18例呼气末二氧化碳(etCO2)升高超过10 mmHg,5例获得持续ROSC并转入ICU,其中4例在随后24小时内达到脑死亡标准,1例在ICU再次发生难治性心脏骤停后死亡。作者认为数据证实REBOA作为标准高级生命支持辅助手段在急诊科和院前阶段的可行性,但非创伤性院外心脏骤停中的生存获益尚未证实,需要大型研究。

要点

  • 难治性院外心脏骤停定义为CPR≥15分钟,且因临床或后勤原因不适合ECPR者,在急诊科和HEMS院前阶段尝试REBOA。
  • 20例中18例成功置管(11例非创伤、7例创伤),2例失败均与反复动脉穿刺失败有关。
  • 从EMS调度到尝试REBOA置管的中心时间为46分钟。
  • 球囊充气后12/18例etCO2升高超过10 mmHg(非创伤8/11、创伤4/7)。
  • 5例获得持续ROSC并转入ICU(创伤1例、非创伤4例),其中4例在随后24小时内达到脑死亡标准,1例在ICU再次难治性心脏骤停后死亡。

适用人群与场景

  • 2019—2020年连续20例难治性院外心脏骤停患者,包括创伤性和非创伤性,CPR≥15分钟,因临床或后勤原因不适合ECPR。
  • REBOA在急诊科和当地HEMS服务的院前环境中实施。

诊断标准与关键阈值

  • 难治性院外心脏骤停:CPR≥15分钟。
  • 不适合ECPR:因临床或后勤原因。

处置流程与药物剂量

  • 对创伤性和非创伤性难治性院外心脏骤停(CPR≥15分钟)且不适合ECPR者,自2019年1月起应用REBOA作为标准高级生命支持的辅助手段。
  • REBOA在急诊科和当地HEMS服务的院前环境中实施。

红旗征与不能漏的情况

  • 2例置管失败与反复动脉穿刺失败有关。

研究设计与关键结果

  • 研究类型:基于Utstein的病例系列;样本量20例;人群为2019—2020年连续难治性院外心脏骤停患者;干预为REBOA辅助标准高级生命支持。
  • 成功置管18/20例(11例非创伤性、7例创伤性),2例失败与反复动脉穿刺失败有关。
  • 从EMS调度到尝试REBOA置管的中心时间为46分钟。
  • 球囊充气后etCO2升高超过10 mmHg者12/18例(非创伤性8/11、创伤性4/7)。
  • 持续ROSC 5例(创伤性1例、非创伤性4例),均转入ICU;其中4例在随后24小时内达到脑死亡标准,1例在ICU再次发生难治性心脏骤停后死亡。

证据类型、等级与局限

  • 证据类型:基于Utstein的病例系列。
  • 局限:作者指出,在创伤性院外心脏骤停中越来越多证据提示REBOA可改善生存,但在非创伤性院外心脏骤停中尚未证实,需要大型研究。

对床旁实践的改变

  • 作者认为数据证实REBOA作为标准高级生命支持的辅助手段在急诊科和院前阶段的可行性。
  • 作者指出,在创伤性院外心脏骤停中越来越多证据提示REBOA可改善生存,但在非创伤性院外心脏骤停中尚未证实,需要大型研究。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

AIMS: Out of hospital cardiac arrest (OHCA) is still a leading cause of mortality worldwide. In recent years, resuscitative endovascular balloon occlusion of the aorta (REBOA) has been progressively studied as an adjunct to standard advanced life support (ALS) in both traumatic and non-traumatic refractory OHCA. Since January 2019, the REBOA procedure has been applied to all the patients experiencing both traumatic and non-traumatic refractory OHCA (≥15 min of cardiopulmonary resuscitation) not eligible for ECPR for clinical or logistic reasons. We aimed at describing the feasibility and effects of REBOA performed both in the Emergency Department and in the pre-hospital environment served by the local HEMS for refractory OHCA.

METHODS: Twenty consecutive patients experiencing refractory OHCA and in whom REBOA was attempted in 2019 and 2020 were included in the study, Utstein data and REBOA specific variables were recorded.

RESULTS: Successful catheter placement was achieved in 18 out of 20 patients, 11 of these were non-traumatic OHCAs while 7 were traumatic OHCAs, the 2 failures were related to repeated arterial puncture failure. Median time between the EMS dispatch and REBOA catheter placing attempt was 46 min. An increase in etCO2 over 10 mmHg was observed after balloon inflation in 12 out of 18 patients (8/11 non-traumatic and 4/7 traumatic OHCAs), a sustained ROSC was observed in 5 patients (1 traumatic and 4 non-traumatic OHCA) that were subsequently admitted to the ICU. Four out of the 5 patients reached the criteria for brain death in the subsequent 24 h while one patient experienced another episode of refractory cardiac arrest in ICU and subsequently died.

CONCLUSION: Our data confirm the feasibility of REBOA technique as an adjunct to ALS in both the ED and prehospital phase and most of the treated patients experienced a transient ROSC after balloon inflation while 5 out of 18 experienced a sustained ROSC. However, while in the trauma setting increasing evidence suggests an improved survival when REBOA is applied to refractory OHCA, in non-traumatic OHCA this has yet to be demonstrated and large studies are needed.

来源:Resuscitation,查看原文。版权归原作者所有。

参考来源

  1. Gamberini L, Coniglio C, Lupi C, et al. Resuscitative endovascular occlusion of the aorta (REBOA) for refractory out of hospital cardiac arrest. An Utstein-based case series. Resuscitation. 2021. PMID: 34089774. doi:10.1016/j.resuscitation.2021.05.019

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。